(Q41481595)

1 October 2017

1 reference

title

Nitric oxide and shock (English)

1 reference

1 October 2017

Kilbourn RG

1

1 reference

PubMed ID

9164422

1 October 2017

Traber DL

series ordinal

2

1 reference

PubMed ID

9164422

1 October 2017

Szabó C

series ordinal

3

1 reference

1 October 2017

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

43

1 reference

1 October 2017

5

1 reference

1 October 2017

277-348

1 reference

Ultimate survival from septic shock

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Profound but reversible myocardial depression in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Peripheral vascular resistance in septic shock: its relation to outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Defective oxidative metabolism of rat liver mitochondria in hemorrhagic and endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Bedside catheterization of the pulmonary artery: risks compared with benefits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitrogen oxide levels in patients after trauma and during sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide: a signal for ADP-ribosylation of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide as a secretory product of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide: a physiologic messenger molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide signaling in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Altered immune responses in mice lacking inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Antioxidants differentially affect nuclear factor kappa B-mediated nitric oxide synthase expression in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Cyclic AMP elevating agents synergize with inflammatory cytokines to induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Protein kinase C activation inhibits cytokine-induced nitric oxide synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Signal transduction mechanisms involving nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The nitric oxide and cGMP signal transduction system: regulation and mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Methylene blue infusion in septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Peroxynitrite formation from macrophage-derived nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The oxidative inactivation of sarcoplasmic reticulum Ca(2+)-ATPase by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

NG-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of nitric oxide formation by guanidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Amidines are potent inhibitors of nitric oxide synthases: preferential inhibition of the inducible isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Aminoguanidine selectively inhibits inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of nitric oxide synthesis is detrimental during endotoxemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Detrimental effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine-methyl-ester) in a murine sepsis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

L-arginine pathway in the sepsis syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysacchride treatment in vivo in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Loss of endothelium-dependent vasodilation in the pulmonary vessels of sheep after prolonged endotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

S-ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Physiologic and molecular characterization of the role of nitric oxide in hemorrhagic shock: evidence that type II nitric oxide synthase does not regulate vascular decompensation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Hemorrhagic shock-induced alterations in circulating and bronchoalveolar macrophage nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effect of graded hypoxia on the induction and function of inducible nitric oxide synthase in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effect of inhibition of nitric oxide synthesis on the cardiovascular and endocrine responses to hemorrhage in conscious rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of S-isopropyl isothiourea, a potent inhibitor of nitric oxide synthase, in severe hemorrhagic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

PAF-acether today--relevance for acute experimental anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Participation of nitric oxide in mouse anaphylactic hypotension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endothelium-dependent relaxation of the rat renal artery caused by activation of histamine H1-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Leukotrienes C4 and D4 are potent endothelium-dependent relaxing agents in canine splanchnic venous capacitance vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

An inhibitor of nitric oxide production, NGnitro-L-arginine-methyl ester, improves survival in anaphylactic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Production of nitric oxide in anaphylaxis in rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Role of nitric oxide in anaphylactic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Hypersensitivity reactions from taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Suspected anaphylactic reaction to Cremophor EL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Shared actions of endotoxin and taxol on TNF receptors and TNF release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of inhalation and intravenous anaesthetic agents on presser response to NG-nitro-L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

N omega-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effect of hemorrhagic hypotension on cerebrovascular reactivity and ultrastructure in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endothelial cell dysfunction occurs after hemorrhage in nonheparinized but not in preheparinized models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Activated neutrophils inhibit cerebrovascular endothelium-dependent relaxations in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Pentoxifylline attenuates the depressed endothelial cell function and vascular muscle contractility following trauma and hemorrhagic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The endothelium-dependent relaxation of human middle cerebral artery: Effects of activated neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Self-limiting enhancement by nitric oxide of oxygen free radical-induced endothelial cell injury: evidence against the dual action of NO as hydroxyl radical donor/scavenger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Role of NO in vascular smooth muscle and cardiac muscle function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide synthase in cultured endocardial cells of the pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide and cardiac function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of calcium channel antagonists on the induction of nitric oxide synthase in cultured cells by immunostimulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Widespread tissue distribution, species distribution and changes in activity of Ca2+ -dependent and Ca2+ -independent nitric oxide synthases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immunohistochemical analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Importance of basal nitric oxide synthesis in regulation of myocardial blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Selective pharmacological inhibition of distinct nitric oxide synthase isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Characterization of a pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Conjugated human hemoglobin as a physiological oxygen carrier--pyridoxalated hemoglobin polyoxyethylene conjugate (PHP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Fatal Cardiac Side Effects of L-NMMA?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Methylene blue administration in septic shock: a clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Expression of inducible nitric oxide synthase in failing and non-failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Expression of inducible nitric oxide synthase in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

Methylene blue increases myocardial function in septic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

Regulation of the expression of the inducible isoform of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model.

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

Isoflurane causes endothelium-dependent inhibition of contractile responses of canine coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

Endothelium-dependent circulatory control--a mechanism for the differing peripheral vascular effects of isoflurane versus halothane

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

Attenuation of endothelium-mediated vasodilation by halothane.

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990028-6

7 January 2021

10.1016/S0011-5029(97)90028-6

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9164422